A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The race to ...
AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes for a potential blockbuster that could be part of a powerful combination ...
LOS ANGELES/LONDON (Reuters) - AstraZeneca Plc has won U.S. approval to market its cholesterol-lowering drug Crestor to treat the clogging of arteries, which may boost sales of the blockbuster drug in ...
Tens of millions of Americans have high cholesterol, which increases the risk of heart disease. Here & Now ‘s Peter O’Dowd ...
LONDON (CBS.MW) -- AstraZeneca on Monday said a study presented at the European Association for the Study of Diabetes shows that its Crestor statin is more effective at reducing bad cholesterol and ...
LONDON, Jan 21 (Reuters) - The patent expires later this year on the world's biggest selling drug, Lipitor, and it is causing a headache not just for maker Pfizer but also for arch-rival AstraZeneca .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback